312գƣȫӹ˾հҩҵ˾ڽյҩֺǩעơҩƷ֪ͨ顷ҩƷͨһۡһֶе㿹ҶͨƻϸĹؼҶԴл̣Ӷϸơ
ŵϽ⸰ƴС311䣬ŵϽƣù˾»鱾˾Ϻ֤ȯƴСڸ۽кŵϽ2020ӭеĴҩBTKƼ²ᣨorelabrutinibڽ2ʱսͶʡ˴⸰ƴУζŵϽµó̡
ϴҩPD-L13ٴ312գϴҩƣ丽˾йҽ˾COFйҩƷල֣NMPAٴ룬ԶԽϻһɢСϸΰSCLCsocazolimabǰZKAB001жġ˫ä3ٴ顣socazolimabһPD-L1¡壬ڽ1йͻƷ֣ڽܹһߺʧܻ߲ܵĸתԹ
ʯҩšС311գNMPA ʯҩŶҩҵ˾4ҩһһУΪһеؿѪܼøƼѪƤ壬ѪСͳάϸ弤øԡ
ҽҩڿƴݽIPO롿311գϺ֤ȯƴ¹ʾʾҽҩƴݽIPO룬310ջй˵飬ҽҩβÿƴб̣Ϊ֤ȯIPOƻļʽ17.8ԪҪҩзĿͲʽ
ʯҩ뿵ŵIL-4RйȨ桿310գʯҩŹȫʸ˾뿵ŵﶩЭ飬CM310(һֿIL-4RԴ)ضԷβ(COPD)ȺϵͳȨҵʯҩż2ԪɱEGF-TKI֮һҪ
ҽҩύɭҩƥ롿310գҩֹʾҽҩύɭҩƥҵʽCDEƥΪһܶO-תøƼڸ/ȶƳ֡\ءɭߡ
ٲ1ҩ̩ʽ NMPA 310գNMPA ʾٲ1ҩע̩յʽҩӦ֢ΪϵͳԺǴ̩ٲҩзİ BLyS APRIL ԭԿںϵҩϵͳԺǴʪԹؽȶ
ݶPI3KƼй걨С310գйҩƷලҩƷģCDEʾݶBayer5.1ҩcopanlisibעöƼй걨ҩ룬CopanlisibһPI3KƼڸԱԵܰMZL˻ߵӦ֢FDAͻƷ϶2020ױCDEͻƷ
PD-L1/CTLA-4˫KN046עٴINDFDA39գҩPD-L1/CTLA-4˫ԿKN046ĹؼٴINDʳƷҩƷල֣FDAͬչһšĵĢעٴо(оţKN046-205, ENREACH-ThymicּKN046(PD-L1/CTLA-4˫Կ)ٰЧԡȫԺԡ
ҩҵ/ͨDz˾ƬС39գҩҵ/ͨ4ҩDz˾ƬѾϣͬDz˾ƬһøƼͨѪﵽЧҪʹ综߸Ѫ֢ijƣСʹҩ֮ơ
ڸ۽ݽIPO롿39գݸ۽¶ҩ˾ѵݽIPO룬ϯΪĦʿͺͨʡһԴھδĴȾԼ֢֡켰ҵһ缰ƷĴҽҩ˾
ѩѧ1ԪAʡ38գѩҩƣӹ˾ѩѩѧ뻪ҽǩˡйѩѧ㶫˾֮AͶЭ顷ļЭ飬ҽѩѧ1ԪɺѩѩѧԼ89.36%ȨҽƳѩѧԼ10.64%Ȩ
ټPD-16Ӧ֢ NSCLC36գټCDE俹PD-1?鵥ƽܲƺּչĶ߾ֲڻתԷСϸΰߵӦ֢롣鵥ĵ6롣
Ʒչٴ顿312գEli Lilly and Company˾ڽ4ٿAACRϹһKRAS G12CƼLY3537982ٴǰоڻٴǰù˾ƻڽ1ٴ飬һѡҩİȫԺDZЧ
FDAһVEGFƼϸ311գAVEO OncologyFDAFotivdativozanibУƸ/ϸRCC껼ߣѾܹ2ǰȫƷFotivdaһһѪƤӣVEGFҰἤøƼTKI
ϸƷ1FDAͨʸ310գVertexFDAϸƷVX-8801ĿͨʸѾصѪǺ͵Ѫʶ1ߵI/II顣
ĬɳݽTIGIT+鵥Ƽٴ롿310գCDEʾĬɳMK-7684AעҺٴѻCDEѯMK-7684AĬɳvibostolimab+pembrolizumab鵥ɵһ̶ƼƼеvibostolimabĬɳһϸTIGITĵ¡壬鵥ǿPD-1
CAR-TƷնӦ֢38գ¿ѧGilead SciencesKite PharmaǰFDACAR-TƷYescartaaxicabtagene ciloleucelչӦ֢Ƹ/ܰFL˻ߡܹȫơŸָǵһƶܰߵCAR-TϸƷ
CDK4/6ƼΨ?ƬйС38գҩCDK4/6ƼΨ?ƬйɹСΨ?ƬһָѡԵCDK4/6Ƽٴǰоʾϸֳյٰϸ˥Ϻ͵
̩IL-6Ƽƺβ36գϣRoche»̩ˣGenentech˾FDAIL-6ƼActemratocilizumabչӦ֢ڼϵͳӲӲƤؼԷβSSc-ILD껼ߵķι½ٶȡŸָActemraFDAĵһƸòƷƷ
ӰҽǧԪAʡ312գӰҽǧԪAʣɿԻͶʡʽڼٻӰҽƺӰҽеIJֺͷչӰҽƺӰҽеļзȫۡ
3ԪBʡ312գBʣܹģ3Ԫнʱн»ͶͶʷͶʣͬʱҩʱʱʱMSA CapitalȻͶʽڴ쿹忪ȫҵƽ̨רҵŶӣԿƶһϵе˫Ʒٴǰٴ顣
оɽԪAʡ312գרעټзͲҵĴоƼ˾ɽԪAʣȤʲͶʽҪƽзͲҵ
ԪAʡ312ջϤ崴ҩзҵϺҽҩ˾ԪAʣʱͶ̩Ͷʺ㴴ͶͬͶʱαʵĶҲʡʽҪƽʽҩIND걨ٴоԼĿĿ
ϺҽƿƼPre-AǧԪʡ310գϺҽƿƼ˾˳Pre-AǧԪʡϤʽڹ˾IJƷз봴¡衢豸̩ϰزҵʱͶʣɲʱβʡ
Ŀɳ1ԪBʡ310գרעڴƷٴۿ\˾Arctic VisionĿɳ1ԪBʡĹʱͶѶOctagon CapitalҵҼ缯ű֣־ղʿͶԭɶϷƼʱ˴Ͷӳ֡ýֹ֧˾Ʒߵٴעἰҵзƽ̨Ĵ²ƷijŶӵչ衣
첩̩ǧԪʹʡ310գ첩̩Ƽ˾ǧʹʣɱѧԭʼ»ͶѧͶʻͬͶʣ첩̩зһҩ˾Ŀĺѡҩɸѡͳҩо
̿ƼɳԪBʡ310գȵ˹ؽҵ̿Ƽ˾ɳԪBʣɻÿʱͶͬΰҵӯʱ͵²ͶʸͶWinX Capital ʱζҲʡ
˹ҩɳ4ԪCʡ310գ˹ҩɳ4ԪCʡйʱͶʻ겴ͶͶͶʡʱɫһȶͶʻʯͶʡнʱ»ȶϹɶͬɡʱڱʽеζҲʡ
ʥҽ1ԪAʡ39գרעݡ߸ֵƷϺʥҽƿƼ˾1ԪAʣͶͶ̩ʱԭйɶͶ
ƼɹԪAʡ39գ˹㷨˾ƼɹԪAʣΪʱʱͶʽ˹㷨SaaSƽ̨зͶ롢չӪŶӡƼ2017ϺһԱռûΪԤ⼰ҵΪҵ˹㷨˾
ҽҩPre A+ʡ39գҽҩPre A+ֵʣ˹ʱͶʣʽڼϸIJ֡ϸҩ↑һߴԺսԵǰؼҽҩǹϸƵҵ
ҶܻC+ʡ38գйܿҵ߸ҶǧԪC+ʣͶʷΪϺ˹ܲҵͶʻ𡣾˽⣬ʽ²Ʒзƿ˺IJƷϲҵƽ̨ٽ̬ϵĽ
ֿƼCʡ38գֿƼ˾ɳ2ԪCʡսͶ˹ٴǡʺֿƼʵɫ뼼쵼ߵλɫסҵҽϵҵзӪ
֪кһɽǧԪʹʡ38գ麣֪кһҵ˾ɽǧԪʹʣ֪ʹͶ˸Ͷɡù˾Ҫ˲Ŵʽȷ档˾ĿǰҲһֵʼƻɱʱγڲʡ
Դڹ˾桢ý屨ȹϢο粻֤ȷԡϢռޣ¼ͶѶֻ漰ҵҵµͶʡеشϢʼϵ
本文由网上采集发布,不代表我们立场,转载联系作者并注明出处